Matthew received a B.S. in biosystems engineering from Michigan State University. His research is currently focused on using a novel, small interfering RNA architecture to improve the stability and potency of spherical nucleic acids for gene regulation therapy. This research involves studying the structure, behavior, and therapeutic efficacy of these spherical nucleic acids in vitro and in a rat model of eye disease, and will contribute to the development of new treatments for cancer and eye diseases.
Sign up for our newsletter to receive information on events, news, and articles.